This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Green Cross Holdings Corporation, The Green Cross Corporation. Active years: 2022-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2023
Title: The Innovative Contributions of Jeong Hye Yoon
Introduction
Jeong Hye Yoon, an accomplished inventor based in Gyeonggi-do, South Korea, has made significant strides in the field of biomedical engineering. With two notable patents to his name, he has focused his research on improving methods for purifying important biological compounds. His contributions not only advance scientific knowledge but also have practical implications in therapeutic applications.
Latest Patents
Jeong Hye Yoon's latest patents reflect his dedication to enhancing purification processes in the biomedical sector. One of his patents, titled "Method of Preparing Composition Containing Factor VIII (FVIII) and von Willebrand Factor (vWF) with Controlled Content of von Willebrand Factor (vWF)," discloses a method for preparing a composition comprising factor VIII and von Willebrand factor. This innovation allows for the controlled mixing of these components, ensuring that the amount of impurities is minimized while also maintaining a quick processing time. Another of his patents, "Method for Purification of Immunoglobulin," presents an improved procedure for purifying immunoglobulins from plasma protein samples, efficiently removing impurities with a streamlined process involving both anion-exchange and cation-exchange chromatography.
Career Highlights
Throughout his career, Jeong Hye Yoon has been associated with prominent companies in the biotechnology sector, including the Green Cross Corporation and Green Cross Holdings Corporation. His work at these institutions has provided him with a platform to develop and refine his innovative solutions in biopharmaceutical purification processes. The impact of his work is felt in various therapeutic contexts, especially in treatments for blood-related disorders.
Collaborations
Jeong Hye Yoon has collaborated with esteemed colleagues, such as Soo-kwang Kim and Kyung Hyun Boo. These collaborative efforts have fostered an environment of innovation, allowing for the sharing of ideas and expertise, further enhancing the field of biomedical research.
Conclusion
In conclusion, Jeong Hye Yoon exemplifies the spirit of innovation in the biotechnology field. His patents and collaborations reflect his commitment to improving methods of purifying critical biological substances, paving the way for better therapeutic outcomes. As he continues to build upon his achievements, the impact of his work is likely to inspire future innovations in biomedical engineering.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
